1. Home
  2. Analysis
  3. Omnaris
  4. Vancomycin-hcl

Omnaris and Vancomycin hcl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnaris (ciclesonide) and Vancomycin hcl (vancomycin hydrochloride). Common drug interactions include tendon rupture among females.

The phase IV clinical study analyzes what interactions people have when they take Omnaris and Vancomycin hcl. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.

What is Vancomycin hcl?

Vancomycin hcl has active ingredients of vancomycin hydrochloride. It is often used in clostridium difficile colitis. eHealthMe is studying from 6,530 Vancomycin hcl users. Check the latest studies of Vancomycin hcl.

On Jul, 21, 2026

11 people who take Omnaris and Vancomycin hcl together, and have interactions are studied.

Omnaris and Vancomycin hcl drug interactions.

What are the common drug interactions of Omnaris and Vancomycin Hcl, by gender? *:

female:

  1. Tendon rupture (tear of tendon)
  2. Surgery
  3. Arthropathy
  4. Limb injury
  5. Road traffic accident
  6. Tooth disorder (tooth disease)
  7. Limb discomfort (discomfort in leg)
  8. Osteomyelitis (infection of bone)
  9. Vomiting
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

n/a

What are the common drug interactions of Omnaris and Vancomycin Hcl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Fall
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Joint injury
  5. Joint swelling
  6. Post procedural infection
  7. Tendon rupture (tear of tendon)
  8. Surgery
  9. Limb injury
  10. Road traffic accident

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 100.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Omnaris and Vancomycin hcl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omnaris and Vancomycin hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omnaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnaris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin hcl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide and vancomycin hydrochloride (the active ingredients of Omnaris and Vancomycin hcl, respectively), and Omnaris and Vancomycin hcl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.